RCEL - Avita Medical Ltd logo

RCEL

Avita Medical Ltd

Net β€”top 1%Rev β€”top 1%Revenue grew 100% of years5Y
Hold

Avita Medical develops acute wound care solutions, primarily through its RECELL System, which uses a patient’s own skin to treat thermal burns and full-thickness skin defects. The company also offers biosynthetic matrices like PermeaDerm and Cohealyx.

βš•οΈ Healthcare NASDAQ Listed 2019 $ AUD
$1,000 invested 10 years ago β†’$1,168today

Score Overview

1 Year
Score
Net Growth11.33%
Net TrendGrew
Net Income Consistencyβ€”
Rev Growth5.62%
Rev TrendGrew
Revenue Consistencyβ€”
5 Years
Scoreβ€”
Net Growthβ€”
Net Trend50%
Net Income Consistencyβ€”
Rev Growthβ€”
Rev TrendEvery year
Revenue Consistencyβ€”
All Time
Score
Net Growth-74.96%
Net Trend33%
Net Income Consistency
Rev Growth14x
Rev Trend83%
Revenue Consistency

See the full market ranking β†’

Avita Medical Ltd fundamental performance

Across Avita Medical Ltd's full reported history, from 2019 to 2025, revenue grew from $ 5M to $ 71M and net income went from -$ 24M to -$ 48M. Revenue increased in 83% of the years measured; net income in 33%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 8.12β€”
1 Year2025-08-12
$ 5.5247.10%
5 Years2021-08-12
$ 17.75-54.25%
10 Years2016-08-12
$ 6.9516.83%
All Time2019-10-01
$ 37.95-78.60%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 75M-$ 43M$ 11M
2025$ 71M-$ 48M$ 18M
2024$ 64M-$ 61M$ 35M
2023$ 50M-$ 35M$ 89M
2022$ 34M-$ 26M$ 79M
2022
2021$ 33M-$ 25M$ 85M
2020$ 5M-$ 24M$ 73M
IPO2019$ 5M-$ 24M$ 20M

Explore beyond RCEL

You're looking at Avita Medical Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies